Inversion Therapeutics
Burlingame, US · Founded 2024 · Delaware corporation
Founders & leadership
JA
James A. Wells, Ph.D.Named on SEC filing
Board
SW
Samad Wahid, M.D.Board director
JC
Jeremy Caldwell, Ph.D.Board director
WM
William Michael Kavanaugh, M.D.Board director
Reported raises · per SEC filings
Form D private placements$6.9M disclosed across 1 round · 2025
▶$6.9MraisedAug 2025 · 4 investors · BiotechnologyRule 506(b)
▶$6.9MraisedAug 2025 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Samad Wahid, M.D.Director
- James A. Wells, Ph.D.Executive Officer, Director
- Jeremy Caldwell, Ph.D.Director
- William Michael Kavanaugh, M.D.Director
- Offering amount
- $11.1M
- Amount sold
- $6.9M
- First sale
- Jun 2025
- Incorporated
- Corporation, Delaware, 2024
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- How much funding has Inversion Therapeutics raised?
- Inversion Therapeutics has disclosed $6.9M raised across 1 round.
- Where is Inversion Therapeutics headquartered?
- Inversion Therapeutics is headquartered in Burlingame, US.